Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomized, double-blind study of the effect of first line treatment with Avastin (bevacizumab) in combination with docetaxel on progression-free survival and disease response in patients with HER2 negative metastatic breast cancer
bevacizumab
BO17708
NCT00333775
malignant neoplasm of breast
Phase 3
 
January 2014

Powered by ideaPoint, Inc.